Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides.
Recent molecular-dynamics simulations have suggested that the arginine-rich HIV Tat peptides translocate by destabilizing and inducing transient pores in phospholipid bilayers. In this pathway for peptide translocation, Arg residues play a fundamental role not only in the binding of the peptide to the surface of the membrane, but also in the destabilization and nucleation of transient pores across the bilayer. Here we present a molecular-dynamics simulation of a peptide composed of nine Args (Arg-9) that shows that this peptide follows the same translocation pathway previously found for the Tat peptide. We test experimentally the hypothesis that transient pores open by measuring ionic currents across phospholipid bilayers and cell membranes through the pores induced by Arg-9 peptides. We find that Arg-9 peptides, in the presence of an electrostatic potential gradient, induce ionic currents across planar phospholipid bilayers, as well as in cultured osteosarcoma cells and human smooth muscle cells. Our results suggest that the mechanism of action of Arg-9 peptides involves the creation of transient pores in lipid bilayers and cell membranes.
Department of Physics, Rensselaer Polytechnic Institute, Troy, New York, USA.
H D
HD
Herce
A E
AE
Garcia
J
J
Litt
R S
RS
Kane
P
P
Martin
N
N
Enrique
A
A
Rebolledo
V
V
Milesi
D000818:Animals; D001120:Arginine; D002462:Cell Membrane / Q000737:chemistry / Q000378:metabolism*; D002463:Cell Membrane Permeability; D002470:Cell Survival; D004553:Electric Conductivity; D015696:Gene Products, tat / Q000737:chemistry / Q000378:metabolism; D054298:Human Immunodeficiency Virus Proteins / Q000737:chemistry; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008968:Molecular Conformation; D056004:Molecular Dynamics Simulation; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism*; D010713:Phosphatidylcholines / Q000737:chemistry / Q000378:metabolism; D010715:Phosphatidylglycerols / Q000737:chemistry / Q000378:metabolism; D016062:Porosity; D021381:Protein Transport; D012492:Salts / Q000737:chemistry / Q000378:metabolism; D014867:Water / Q000737:chemistry / Q000378:metabolism
D015696:Gene Products, tat; D054298:Human Immunodeficiency Virus Proteins; D010455:Peptides; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; D012492:Salts; D014867:Water; C051388:1,2-dioleoyl-sn-glycero-3-phosphoglycerol; D001120:Arginine; C017251:1,2-oleoylphosphatidylcholine